VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Recruiting
Observational Study
Hepatic Disorders
Intestinal Failure-associated Liver Disease
Cystic Fibrosis Liver Disease
MAFLD
Pediatric Liver Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 25
- Sex
- Any
- Study type
- Observational
- Participants needed
- 550 (estimated)
- Sponsor
- Sahlgrenska University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational (diagnostic validation) study is to validate imaging-based biomarkers for assessing liver involvement in pediatric patients with established or suspected liver disease. The projekt involves 3 larger studies, each with specific aims specified in detailed description below.
The main study (study 1) compares imaging-based biomarkers-with liver biopsy to evaluate their …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (Study 1-main study)
* all patients scheduled for a clinically liver biopsy at the Queen Silvia Children's Hospital
* any form of suspected or confirmed liver disease
* age between 0-18 years
* consent by the child/parents to participate.
* For controls: children scheduled for a …
Contacts